Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says
This article is from
The Cancer Letter
archive.
Vol. 20 No. 33 | August 19, 1994
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Concepts For Education Initiatives In Breast Ca Approved As RFA
July 9, 1993
TCL Archive
FDA News: ODAC Clears Photofrin For Microinvasive NSCLC
September 26, 1997
TCL Archive
Funding Opportunities
February 7, 2003
TCL Archive
New Grants Awarded In Tobacco Research
February 17, 1978
TCL Archive
FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”
June 24, 2011
TCL Archive
Consensus Conference Planned On Adjuvant Chemotherapy For Breast Cancer
March 22, 1985
